Related Experiment Video

Updated: Sep 26, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1

Atsuo Sasaki1, Takaharu Taketomi, Reiko Kato

  • 1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Nature Cell Biology
|April 30, 2003
PubMed

Insights

Sprouty4 protein inhibits vascular epithelial growth factor (VEGF)-induced signaling by binding Raf1, revealing distinct pathways for receptor tyrosine kinase activation. This clarifies Sprouty4

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Cancer research

Background:

  • The Raf-MAPK-ERK cascade is crucial for cellular regulation.
  • Raf activation mechanisms, both Ras-dependent and independent, are not fully understood.
  • Sprouty and Spred proteins negatively regulate ERK activation.

Purpose of the Study:

  • To clarify the molecular functions of mammalian Sprouty proteins.
  • To investigate Sprouty4's role in regulating Raf1 and ERK activation.
  • To determine the specific pathways Sprouty4 targets.

Main Methods:

  • Investigated Sprouty4's effect on VEGF- and EGF-induced Raf1 activation.
  • Analyzed Sprouty4 binding to Raf1 using its carboxy-terminal domain.
  • Utilized Sprouty4 mutants to assess the role of its amino-terminal region.

Main Results:

  • Sprouty4 suppresses VEGF-induced, Ras-independent Raf1 activation.
  • Sprouty4 does not affect EGF-induced, Ras-dependent Raf1 activation.
  • Sprouty4 binds Raf1 via its cysteine-rich domain, essential for inhibition.
  • Sprouty4 inhibits VEGF-induced ERK signaling independently of its N-terminal region.

Conclusions:

  • Receptor tyrosine kinases utilize distinct pathways for Raf and ERK activation.
  • Sprouty4 acts as a differential regulator of these distinct signaling pathways.
  • Sprouty4's interaction with Raf1 is key to its inhibitory function in specific signaling contexts.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: